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Abstract Low-protein diets have been advocated for
many decades as the cornerstone in the treatment of
chronic kidney disease. Initially, the low intake of protein
was used to reduce uremic symptoms; thereafter, albeit
controversial, evidences suggested that dietary protein
restriction can also slow the rate of progression of renal
failure and the time until end-stage renal disease. This
reviews focuses on the dietary factors and their influence
on the loss of renal function and on the evidences in the
literature supporting a nephroprotective role of the low-
protein diet.
Keywords Chronic kidney disease  Glomerular filtration
rate  Low-protein diet  Protein intake
Introduction
Chronic kidney disease (CKD) is a common disorder and
its prevalence is increasing worldwide. Early diagnosis
could permit early intervention not only to slow the pro-
gression to end stage renal disease (ESRD), but also to
reduce the risks of cardiovascular (CV) events and death
that are associated with CKD. Effective strategies are
available to slow the progression of CKD and reduce CV
risk. In this context, a central role is certainly played by
nutritional dietary treatment.
The use of a low-protein diet in treating CKD is still a
matter of debate. Despite a universal agreement on the
amount of protein intake to prescribe in patients with
advanced CKD does not exist, dietary restriction of pro-
teins and sodium still remains a cornerstone in the treat-
ment of CKD. Initially, in the early 1960s, the low intake
of protein was used to reduce uremic symptoms [1]. Later,
experimental studies hypothesized that high protein load
could cause hyperfiltration and, as a result, the worsening
of renal function [2], and the low-protein diet became
widely used in the belief that it could slow down the pro-
gression of chronic renal failure.
Despite controversy still exists about the potential ben-
eficial effect of reduction in dietary protein on the course
and rate of progression of loss of renal function, most
studies and clinical practice suggest that lowering protein
intake allows to correct several metabolic complications of
renal failure: in particular, the reduced protein intake is
able to reduce the alimentary load of phosphate, hydrogen
ions and sodium, ameliorating the hyperphosphatemia,
secondary hyperparathyroidism, acid–base balance control
and hypertension [3].
Although high-degree scientific evidence is lacking, the
interest in the use of the low-protein diet in clinical practice
increased, and the historical aims for a use of dietetic
therapy in CKD, that was handling of uremic symptoms,
has changed, highlighting the role of low-protein diet in the
more general topic of nephroprotection.
Dietary factors and influence on the loss of renal
function
Several dietary factors related to the protein intake can
affect the loss of function and the severity of kidney dis-
ease. When examining dietary constituents that directly
influence the severity of kidney disease, it is important to
remember that higher-protein diets are also generally
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higher in the content of sodium, uric acid precursors and
phosphorus (Table 1).
In particular, the dietary salt influences blood pressure
(BP) [4, 5]: a randomized trial compared the short-term
effects of dietary salt restriction added to angiotensin-
converting enzyme inhibitors (ACEi) and/or angiotensin
receptor blockers (ARBs), on proteinuria and BP in CKD
stage 1–2 patients; reduction of salt intake to 6 g/day
enhances the urinary protein e BP lowering effect of either
ACEi and ARBs [6].
Another dietary influence on the degree of kidney
damage is uric acid production: high-protein diet is asso-
ciated with an increase in the risk of raising serum uric acid
and the development of gout [7], and these associations are
magnified in CKD patients. In experimental models of
CKD, a high serum uric acid raises BP and is associated
with more intense vascular inflammation [8]. In patients
with hypertension, reducing the serum uric acid level with
allopurinol can lower BP independently of antihyperten-
sive medications [9].
A third diet-related factor that adversely affects kidney
function is a high serum phosphorus concentration: when
kidney function is impaired and the diet is rich in protein,
serum phosphorus increases to raise the risk of developing
secondary hyperparathyroidism [10]. Based upon cumu-
lated data Lau [11] expressed the ‘‘precipitation-calcifica-
tion hypothesis’’ as the main mechanism of renal damage
by phosphorus. According to this hypothesis, the filtered
load of phosphorus per renal tubule increases, as a conse-
quence of increased blood phosphate level and increased
single nephron GFR, leading to an increased tubular lumen
phosphorus burden and concomitant transepithelial phos-
phate traffic. Sodium, phosphorus and uric acid are also
associated with enhanced cardiovascular mortality in CKD
[12].
In 1982, Brenner and colleagues [13] proposed that the
progression of kidney damage in CKD is directly linked to
an increase in glomerular hemodynamics or ‘‘hyperfiltra-
tion’’; the mechanism is similar to the adaptive response
that occurs to compensate for the loss of renal mass [14].
For the first time, they showed experimentally that hemo-
dynamic changes associated with kidney damage were
reduced by restricting dietary protein [13, 15, 16].
Excess of dietary proteins also increases proteinuria, a
surrogate marker for progression of renal disease [17]. The
mechanism for increasing proteinuria includes hyperfiltra-
tion, but acid can also play a role because a high-protein
diet contains precursors of sulfates and phosphates, which
increase the release of aldosterone [18–20]. In the presence
of proteinuria, increased dietary protein alters glomerular
permselectivity [16], increasing urinary albumin loss [21–
23] and resulting in a decrease in serum albumin concen-
tration among patients with nephrotic syndrome [23].
Additionally, dietary protein also delivers an increased
acid load per nephron providing a non-hemodynamic
mechanism promoting renal injury through the induction of
endothelin and aldosterone in response to increased neph-
ron ammonia generation [21]. Acid loading may also
promote progression of renal disease by increasing the
degree of renal hypertrophy [24, 25]. Dietary factors most
directly increase the risk of uremic toxin-induced damage
to the kidney. Most nitrogen-containing toxins generated
by the metabolism of amino acids accumulate because of
impaired excretion [26, 27].
Clinical effects of a low-protein diet
The beneficial clinical effects of the protein-restricted diets
are largely due to their lower content of sodium, uric acid
precursors, potassium and phosphorus.
Phosphorus, which plays a crucial role in the progres-
sion of renal disease, has been shown to be an independent
risk factor for death in hemodialysis patients. Thus,
reducing the phosphorus intake by decreasing dietary
proteins may slow the progression of renal disease and may
reduce the levels of both phosphorus and parathyroid
hormone [28]. It has been evidenced that even a slight
actual reduction of protein intake of 0.2 g/kg of body
weight per day is sufficient to achieve a significant meta-
bolic improvement of hyperphosphatemia and hyperpara-
thyroidism [3]. Finally, reduced phosphorus intake and
serum phosphorus levels can also enhance the effects of a
low-protein diet on proteinuria and, likely, CKD progres-
sion to renal death [29]. Hypocalcemia is typically asso-
ciated with CKD. It is due to the reduced intestinal
Table 1 The influence of diet on the progression of renal
insufficiency
1. Changes in the measurement of the rate of loss of kidney
function [20]
(a) An acute change in dietary protein causes a parallel change in
measured glomerular filtration rate (GFR)
2. Creatinine production changes with dietary protein [20]
(a) An increase or decrease in protein intake reciprocally change
serum creatinine or eGFR
(b) The new steady state after changing the diet occurs in
*4 months
3. Protein-associated dietary factors affecting progression of CKD
(a) Salt and hypertension [4–6, 41]
(b) Uric acid and hypertension/inflammation [7–9]
(c) Phosphates and kidney injury [10–12, 28, 29]
4. Direct effects of protein intake and progression of CKD
(a) Net acid load and aldosterone/hypertrophy [18–21, 24, 25]
(b) Albuminuria/proteinuria via hyperfiltration [13, 17–23]
(c) Protein-derived nephrotoxins (e.g., indoxyl sulfate) [26, 27]
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absorption of calcium and the spontaneously reduced pro-
tein intake that occur in patients with progressive renal
disorders. Activated vitamin D and calcium supplements
should be administered to patients who are following low-
protein diets to prevent secondary hyperparathyroidism;
the doses should be correlated with actual renal function
and protein intake.
It has been shown that the reduction of protein intake in
CKD improves the lipid profile by reducing the levels of
cholesterol, triglycerides and also lowering lipoprotein AI
and the Apo-AI:Apo-B ratio [30]. In the same way, after
3 months of low-protein diet, the insulin sensitivity of
patients improved and their fasting serum level, need for
daily insulin, blood glucose production were reduced [31].
During the MDRD study, moreover, serum bicarbonate
levels increased markedly in both stage 3 and 4 CKD
intervention cohorts in association with a reduction in
protein intake of 0.2 g/kg body weight/day [32]. A 2007
study by Bellizzi and co-workers [33] showed that BP
control improved markedly in patients with CKD on a very
low protein diet supplemented with ketoanalogs, while
there was no change in the two groups of patients whose
protein intake were not modified. The decrease of protein
intake of about 30 % was associated with a 28 % drop in
sodium intake. Finally, many studies have confirmed that
low protein diets have a favorable effect on the rate of
urinary protein excretion, and a linear relationship between
reduction in dietary protein intake and decrease in pro-
teinuria has been reported in a number of clinical trials
[34].
Clearly, success with a protein-restricted diet depends
on providing the requirements of different nutrient while
regularly assessing nutritional adequacy to avoid malnu-
trition. The minimal amount of calories required by
patients with uncomplicated CKD is 30–35 kcal/kg/day
[35].
Protein restriction and progression of renal
insufficiency: evidence of the literature
Several evidences in the literature indicate that restricting
dietary protein might limit damage and prevent the loss of
kidney function (Table 2). As early as the 1930s, Chanutin
and colleagues [36, 37] demonstrated that restricting die-
tary protein protected rat models of CKD against pro-
gressive kidney damage: specifically, they found that
restricting dietary protein reduced histologic damage and
BP while improving the survival of rats with CKD [13, 15,
16]. These experimental results were consistent with
Table 2 Characteristics of studies examining effects of protein-restricted diets
Study
(references)
Number of
participants
Interventions Results
Maschio
[38]
83 LPD (0.6 g/kg/day) vs unrestricted diet Slower loss of renal function with LPD
Rosman
[41]
247 Protein-restricted diet (0.90–0.95 g/kg/day for GFR 30–60 mL/
min; 0.70–0.80 g/kg/day for GFR 10–30 mL/min) vs
unrestricted diet
50 % reduction of renal death with protein-
restricted diet
Ihle [42] 72 Protein-restricted diet (0.4 g/kg/day) vs unrestricted diet Reduction of progression to dialysis with
protein-restricted diet
Williams
[45]
95 LPD (0.6 g/kg/day) vs unrestricted diet No difference in renal disease progression
NCDS [46] 456 1.0 vs 0.6 g/kg/day Renal survival slightly increased with 0.6 g/
kg/day
Malvy [28] 50 LPD (0.6 g/kg/day) vs VLPD (0.3 g/kg/day) ? ketoacids No difference in renal survival
MDRD [47] 585 Study A: 0.6 vs 1.4 g/kg/day (GFR 25–55 mL/min) Study A: no difference in GFR decline
Study B: 0.3 ? ketoacids vs 0.6 g/kg/day (GFR 13–24 mL/min) Study B: GFR decline slower with 0.3 g/kg/
day
Menon [50] 255 LPD (0.6 g/kg/day) vs VLPD (0.3 g/kg/day) VLPD increases risk of death
Cianciaruso
[3]
423 Moderate protein diet (0.8 g/kg/day) vs LPD (0.6 g/kg/day) Better metabolic control with LPD
Cianciaruso
[53]
423 Moderate protein diet (0.8 g/kg/day) vs LPD (0.6 g/kg/day) No difference in risk of death and dialysis
initiation
Bellizzi [54] 9610 VLPD (0.3–0.4 g/kg/day) ? ketoacids vs no VLPD Longer survival with VLPD in younger
patients (\70 years) and in those without
CV disease
LPD low-protein diet, GFR glomerular filtration rate, NCDS national cooperative dialysis study, VLPD very low-protein diet, MDRD modifi-
cation of diet in renal disease, CV cardiovascular
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reports about small numbers of patients with CKD who
benefited from dietary protein restriction [38, 39]. The
benefits of protein restriction concern both glomerular
hemodynamic and other non hemodynamic processes.
Low-protein diets reduce the single nephron GFR, espe-
cially by reducing glomerular hypertension that occurs
with the loss of functioning nephrons. Moreover, protein
restriction decreases profibrotic cytokines, reduces glo-
merular and tubular growth and can limit plasmatic renin
activity.
One of the earliest trials examining the effects of a low-
protein diet on the progression of CKD was reported by
Maschio et al. [38]. They compared three groups of
patients. Groups I and II had initial serum creatinine values
(Scr) of 1.6–2.7 and 2.9–5.4 mg/dl, respectively. Both
groups were prescribed a diet containing 0.6 g of pre-
dominantly high-quality protein per kg, 40 kcal energy
intake per kg, 650 mg of phosphorus and 1.0–1.5 g of
calcium daily. Group III (initial Scr, 1.6–4.7 mg/dl) con-
sumed an unrestricted diet and served as the control group.
Progression was assessed by evaluating changes in Scr.
Notably, the loss of renal function in groups I and II was
far slower than in group III. In 1989, these same
researchers reported results from 390 patients treated with
a low-protein diet for 54 ± 28 months [40]. They found
that 57 % of the patients had stable Scr values, 11 % had
slower deterioration (defined as a decrease in the decline of
Scr -1 at a rate exceeding -0.02 but less than -0.04 dl/
mg per month), while 32 % had more rapid loss of kidney
function (C0.04 dl/mg per month).
These data were confirmed by Rosman et al. [41] that
reported results from 247 patients after 2 or 4 years of
protein-restricted diets. Actual protein intake was
0.90–0.95 g/kg/day in patients with GFR values between
30 and 60 mL/min and 0.7–0.8 g/kg/day when GFR values
were between 10 and 30 mL/min. Control patients had an
unrestricted diet. After 4 years, renal death was markedly
improved in those assigned to the more restricted dietary
protein (60 vs 30 %, p \ 0.025), with a good compliance
to the diet and no malnutrition signs.
Moreover, Ihle et al. [42] studied 72 Australian patients
with advanced CKD for 18 months (initial GFR \15 ml/
min) that were randomly assigned to an unrestricted diet or
to 0.4 g protein/kg/day. The outcome was evaluated from
measurements of GFR. On average, there was no loss of
GFR in the low-protein diet group, and fewer patients
progressed to dialysis when compared with the unrestricted
diet group (p \ 0.005). Again, patients in low-protein diet
reduced their weight, without anthropometric changes or
variations in albumin levels. However, it is noteworthy that
the conclusion that nutritional status did not deteriorate
with protein restriction could be premature, since further
more accurate exams may be needed to evaluate the
presence of sarcopenia, whose occurrence is increased by
the protein restriction [43, 44].
Williams and colleagues [45] studied 95 British patients
with CKD for 18 months after randomly assigning them to
receive a diet of 0.6 g protein/kg/day and unrestricted
dietary protein; a third group received no dietary protein or
phosphate restriction. The authors found no differences in
the rate of loss of creatinine clearance or in the beginning
of dialysis therapy.
The Northern Italian Cooperative Study Group evalu-
ated 456 CKD stage 3–4 patients, assigned for 2 years to a
control diet of 1.0 g protein/kg/day or to a diet containing
0.6 g protein/kg/day. The results indicated that ‘‘renal
survival’’ was only slightly different; fewer patients in the
low-protein diet group reached the predetermined endpoint
(p = 0.059) [46].
Malvy et al. [28] studied a different diet: restriction to
0.3 g protein/kg/day plus a supplement of ketoacid pre-
cursors of essential amino acids (Ketosteril, 0.17 g/kg/
day). The control patients were prescribed 0.65 g protein/
kg/day. Fifty patients with CKD stage 4–5 (creatinine
clearance B20 mL/min) were included in the study and
they were evaluated for differences in the progression to
dialysis or to a creatinine clearance\5 mL/min/1.73 m2. It
was concluded that renal survival was not different
between the two groups.
The largest study to date is the modification of diet in
renal disease (MDRD) study that examined more than 800
randomly assigned patients for an average of 2.2 years. In
this study were evaluated both the effects of diet and the
strict control of BP in four groups of patients with CKD
stage 3–4 (Study A) or only with CKD stage 4 (Study B).
In Study A (GFR 25–55 mL/min/1.73 m2), the prescribed
diets consisted of 1.4 g protein/kg/day compared with 0.6 g
protein/kg/day. In Study B (GFR 13–24 mL/min/1.73 m2),
patients were prescribed a diet with 0.6 g protein/kg/day or
0.3 g protein/kg/day plus a ketoacid supplement. No dif-
ference in the overall rates of GFR decline was detected in
the two Study A groups. The low-protein diet was associ-
ated with a faster decline in GFR initially; this was
attributed to hemodynamic changes rather than to pro-
gressive kidney damage. In Study B, the loss of GFR was
somewhat slower in patients prescribed the 0.3 g protein/
kg/day diet plus ketoacids than in patients prescribed the
diet containing 0.60 g protein/kg/day (p = 0.07). The
secondary analyses demonstrated that if the rate of loss of
GFR is analyzed according to actual protein intake, the
outcome was positive because the rate of decline in GFR
was strongly related to actual protein intake (p = 0.011) as
was the number of patients progressing to dialysis or death
(p = 0.001) [47]. Specifically, reducing dietary protein by
0.2 g protein/kg/day slowed the loss of GFR by 1.15 mL/
min/year and reduced renal death by 49 %. Moreover, it
Clin Exp Nephrol
123
Author's personal copy
significantly increased bicarbonataemia and reduced blood
urea nitrogen and phosphorus.
Shortcomings of the MDRD study have been identified
[48, 49]. In the first four months of Study A, a sharp
decrease in GFR in the protein-restricted group was related
to physiologic reduction in glomerular hemodynamics.
Subsequently, the loss of GFR was slowed. Moreover,
patients were randomly treated with angiotensin-converting
enzyme inhibitors; finally, the duration of the MDRD study
was only 2.2 years. A recent long-term follow-up of
MDRD patients examining the effect of a very low-protein
diet on the development of kidney failure and death
showed that assignment to a very low-protein diet did not
delay progression to kidney failure, but appeared to
increase the risk of death [50].
On the other hand, the study published by Di Iorio et al.
[51] evaluated the effect on the requirement of erythro-
poietin (Epo) in a group of 10 patients, randomly assigned
to a ketoanalogues supplemented diet (0.3 g protein/kg/
day) vs the use of a diet with a protein intake of 0.6 g/kg/
day. The decreased need for EPO could be explained by the
reduction of parathormone levels likely due to the modest
phosphorus intake with the very low-protein diet, and to the
chelating effects on phosphorus of the calcium salts content
in the mixture of ketoanalogs.
Recently, a prospective randomized controlled trial
(RCT) of Brunori et al. [52] evaluated the efficacy of ke-
tonalog-supplemented diet in elderly patients ([70 years)
with CKD stage 5; 112 patients were randomized to two
groups: one started dialysis with GFR 5–7 ml/min, while
the second started a supplemented diet. The patients in the
diet group had started dialysis an average of 10 months
after the beginning of the diet; moreover, in this popula-
tion, morbidity was significantly lower than in patients that
started dialysis. Good control of uremic symptoms with
this type of diet has allowed to postpone the beginning of
dialytic therapy that was started with GFR values of
4.3 ml/min, a value that is lower than what is suggested by
current guidelines.
Finally, Cianciaruso et al. [3, 53] compared in a RCT the
effects of two diets with different protein content (low- vs
moderate protein diet, protein intake 0.55 vs 0.80 g/kg/day)
in 423 patients with CKD stages 4–5. During the
18 months of the trial, in patients assigned to the low-
protein diet, nine progressed to dialysis or had a doubling
of the serum creatinine [3, 53]. Their study represented the
first evidence that in CKD patients a protein intake of
0.55 g/kg/day, compared with a 0.8 g/kg/day, guarantees a
better metabolic control and a reduced need of drugs,
without a substantial risk of malnutrition [3]. However, the
low-protein diet did not decrease the risk of death or
dialysis therapy initiation compared with the moderate-
protein diet [53]. On the contrary, Bellizzi et al. [54] have
recently showed that very low-protein diet is associated
with longer survival in younger (\70 years) CKD patients
and in those without cardiovascular disease.
To increase the number of subjects studied when ana-
lyzing protein-restricted diets and progression to kidney
failure, a series of meta-analyses have been conducted.
The criterion analyzed in RCTs was renal death. The
analyses were chosen to reduce biases and to increase the
robustness of conclusions. To carry out the meta-analysis,
were used the data of 1494 patients (753 in protein-
restricted dietary groups and 741 control patients assigned
to a higher dietary protein) representative of the entire
population reported in previous studies [55]. It was found
that there was a 39 % reduction in renal death
(p \ 0.001).
In 2006, were published the results of cochrane meta-
analysis which showed that 16 patients should be treated
with a low-protein diet (NNT = number needed to treat) to
‘‘rescue’’ a patient per year from the beginning of dialysis
and renal death (NNT range: 2–56). This result is better
than that reported in the study on the effectiveness of
statins in the study 4S (NNT = 30) or in the study of
primary prevention WOSCPS (West of Scotland Coronary
Prevention study) (NNT = 111) [56].
Fouque and Laville [57] performed a meta-analysis of
ten clinical trials, including a total of 2000 randomly
assigned non diabetic patients. They concluded that the risk
of renal death among patients with stage 3 CKD consuming
either a protein intake of 0.6 versus 1.1 g/kg/day was 0.68
[range 0.55–0.84 (p \ 0.001)].
Conclusions
There is general agreement on the effect of dietary protein
restriction on reducing the rate of loss of GFR among most
forms of renal injury in humans [58, 59]. There are several
potentially injurious pathways that have been well estab-
lished whereby diets containing high levels of protein
should facilitate renal injury [14, 21]. Dietary protein
restriction reduces the histological damage and slows the
progression of renal disease in experimental animals.
Therefore, although high-degree evidence is lacking, it is
recommended to start a nutritional treatment in the early
stages of CKD.
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